ABSTRACT: Prednisolone is known to exist in two anhydrous solid polymorphic forms. The substance is known to degrade upon melting, resulting in erroneous melting data, as shown by the widely scattered results reported in the literature. In this article, thermal analyses carried out at different scan rates show that the onset temperature and the enthalpy value of the signal increase with the scan rate and reach plateau values for high scan rates. Owing to flash scanning calorimetry, the plateau value for the temperature has been identified as the "true" temperature of melting of both polymorphs. This consistent set of new thermodynamic data on the two solid forms leads to the conclusion that both forms are unambiguously enantiotropes of each other. The solid−solid transition has been observed experimentally for the first time and has been confirmed by calculation.
INTRODUCTION
Prednisolone is a corticosteroid used to treat a number of conditions, such as inflammation, allergies, asthma, and vision problems. This drug is available in different forms such as solution, tablet, syrup, suspension, or liquid.
Anhydrous prednisolone is known to exist in two crystal modifications. Forms I and II crystallize respectively into the monoclinic and the orthorhombic crystal systems. 1 From thermal analysis experiments, it was found that Form I melts at a higher temperature (between 236.5 and 239.0°C) with a higher melting entropy than Form II (between 223.8 and 227.7°C
). The authors from ref 1 then concluded that both forms behave enantiotropically at ordinary pressures with a transition point estimated between 120 and 130°C, but were never experimentally observed. Form II is thus the thermodynami cally most stable form at room temperature and Form I the most stable polymorph above the transition point. Prednisolone is reported to degrade upon melting, 2 as evidenced by both mass and heat flow vs temperature curves, thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) curves, respectively. The DSC peak shapes are very rough during and after melting of the two forms 1, 3 and an important weight loss is visible during melting. 1, 3 It was previously proved that degradation occurring upon melting is favored when DSC experiments are carried out at low scan rates. 4, 5 This is the reason why the melting temperature as well as the associated enthalpy of prednisolone polymorphs are most of the time given within a large interval of values, but not as well defined values. 1, 2, 6 It is therefore certain that the integration of the apparent melting peaks provides erroneous melting enthalpy. In order to avoid degradation upon melting, it was previously shown that DSC analysis has to be carried out at high scanning rate. 4, 5 In the present article, Forms I and II were analyzed by conventional DSC experiments with heating rates ranging from 2 to 60°C·min −1 , to propose accurate values for temperatures and enthalpies of melting, based on previous protocol experiments established for ascorbic acid 4 and p synephrine. 5 The melting temperature of both solid forms were also determined by flash DSC (FDSC) and compared to the values obtained by conventional DSC.
EXPERIMENTAL SECTION
The differential scanning calorimetry (DSC) and thermogravi metric analysis (TGA) experiments were performed using two devices, namely DSC 822e and a TGA/DSC 1 from Mettler Toledo (Switzerland), under nitrogen gas. Indium and Zinc (99.9% of purity) were used for temperature and enthalpy calibration of the DSC device. The DSC experiments were carried out at different scan rates from 5 to 60°C·min
FDSC experiments were carried out with a Mettler Toledo Flash DSC1 at a heating rate of 1000 K·s −1 . The measuring cell was continuously flushed with nitrogen gas. High purity indium was used for temperature calibration of the sensor. A small crystal of a few tens of nanograms was placed under a microscope directly on the active area of the sensor, which is circular with a 500 μm diameter. Although such a sample mass cannot be directly determined by weighing, one can never theless have access to this parameter by comparing a given heat of fusion obtained with the FDSC to the corresponding one measured with a conventional DSC device. 7 The standard uncertainties on the temperature and enthalpy data were determined from the standard deviation of three independent measurements.
X ray powder diffraction profiles were recorded using a high resolution INEL diffractometer equipped with a CPS (curve position angular sensitive detector) 120 position sensitive multi detector (Debye−Scherrer geometry, transmission mode, Cu Kα 1 radiation (λ = 1.5406 Å)).
Crystal structure was determined with the reflex plus module of Materials Studio Modeling 5.5. 8 First, the pattern was indexed by means of the peak picking option of the software package. Potential solutions for cell parameters and space group were found using the X cell algorithm. 9 Then, a Pawley profile fitting procedure was applied including refined cell parameters experimental profile fitting with pseudovoigt function, zero shift, and asymmetry Finger Cox Jephcoat function. 10 The structure refinement was achieved using the Rietveld method, rigid body molecular units, overall isotropic factor, and March Dollase preferred orientations. 11 Saturated solutions of commercial prednisolone (Form I) were placed in pierced containers at room temperature to favor very slow evaporation of the solvents. Crystals of Form I grew after ethanol or acetone evaporation and crystals of Form II after anhydrous methanol evaporation.
RESULTS AND DISCUSSION
If we analyze the reported melting data of prednisolone Forms I and II (Table 1) , many contradictions exist for both temperatures and enthalpies of melting. If we refer to Table 1 , and more particularly to the results from ref 6, one can observe that the melting domains overlap, and then it becomes difficult to conclude safely that Form I melts at a temperature higher than that of Form II. Indeed, the order of stability could be inverted. In other words, no conclusions can actually be drawn from these conflicting values. In all reported cases, the II−Ior I−II transition point has never been observed. This questioned the enantiotropic behavior of the system. The second observation from Table 1 concerns the disparity of the results reported. This leads to the conclusion that the temperatures and enthalpies of melting of the two solid forms are in fact not precisely known.
First, the XRPD patterns of the two polymorphs of prednisolone were recorded at room temperature (295 K for Form I and 298 K for Form II). The cell and space groups were found to match with the ones previously reported from crystal structure determination on single crystal at 220 K.
1 Form I crystallizes in the monoclinic P2 1 space group and Form II in the orthorhombic P2 1 2 1 2 1 space group. The cell parameters best reproducing the diffraction patterns at room temperature are given in Table 2 . As observed, they agree with the previously reported ones at room temperature. The expansion of the unit cell remains very low with temperature. Indeed, the cell volume increases only about 1% between 220 K and room temperature. The already published conformations of the molecules 1 were taken as the starting point to refine the structures at room temperature. The final Rietveld refinements converged to a final Rwp value of 7.42% for Form I and 5.06% for Form II (Figure 1) . The commercial prednisolone Form I was examined by DSC at various heating rates from 2 to 60 °C·min . At low heating rate, i.e., 5 °C·min , degradation is confirmed upon melting ( Figure  2 ) whereas, for a heating rate of 60 °C·min −1 , the degradation can be bypassed during melting and manifests itself later.
As shown in Figure 3 , the melting temperature as well as the melting enthalpy of Form I increase with the DSC heating rate. This dependence was previously reported 6 but is in contra diction with the conclusion of Veiga et al. 3 Both parameters reach a plateau value at high heating rates. The melting temperature of Form I could therefore be extrapolated from this plateau at 256.7 ± 0.9 °C( Figure 3A, Table 1) , much much higher than the literature values. As far as the melting enthalpy is concerned, the plateau is reached for a value of 110.8 ± 0.9 J· g −1 (39.9 ± 0.3 kJ·mol
) as shown in Figure 3B and gathered in Table 1 . This value is, on average, 10 kJ·mol −1 higher than the literature data. As previously demonstrated for other substances degrading upon melting, 4,5 the degradation has been bypassed for high DSC scanning rates, giving access to only the melting of prednisolone, the degradation process being shifted to higher temperatures. Owing to this approach, the so obtained values, both for temperature and enthalpy, can be assimilated to true melting data.
The same protocol was followed for prednisolone Form II. The melting temperature of Form II can be determined by extrapolation at 249.3 ± 0.8 °C from Figure 4A and the melting enthalpy can be obtained at the plateau value of 118.1 ± 1.3 J· g −1 (42.6 ± 0.5 kJ·mol ) from Figure 4B . These values are gathered in Table 1 . As for Form I and for the same reasons, the so obtained data are higher than the literature data determined at lower DSC scan rates.
In order to confirm these results, the melting points of both solid forms of prednisolone were examined by FDSC with a heating rate of 1000 K s −1 ( Figure 5 ). The melting temperature of Forms I and II were found to be respectively 257 ± 2 °C and 248 ± 2 °C. These values are in very good agreement with the values determined from the previous graphs. Moreover, previous investigations carried out by FDSC at different scan rates, with Form I and with the sesquihydrate of prednisolone, led to a melting temperature of Form I located between 250 and 260 °C.
14 Form II melts at a lower temperature but with a higher enthalpy than Form I. This confirms that both polymorphs are enantiotropically related, 1, 15 and that a II−I transition point should exist. In order to evaluate the temperature and the enthalpy of this II−I transition point, based on the first principle of thermodynamics, a Hess cycle is applied, assuming the Cp variations between the solid and the liquid states are negligible in the considered temperature range. Hence: Surprisingly and in a random manner, some DSC curves carried out on prednisolone Form II revealed a small endothermic peak at around 154°C, as shown in Figure 6 for a scan rate of 20°C·min −1 . Consistent with the above calculation, this signal could be associated with the II−I transition point. The associated enthalpy was found to be 1.3 J· g −1 , much lower than the calculated one (7.3 J·g
−1
). This suggests that the II−I transformation is not complete, as confirmed by the onset temperature of the melting peak close to 245°C. This temperature, if we refer to Figures 2A and 3A , corresponds to the melting point of Form II for a scanning rate of 20°C min 
CONCLUSION
The implementation of the "DSC method", previously developed to determine the true melting data of ascorbic acid and p synephrine, 4, 5 was applied here in the case of the two polymorphic forms of prednisolone. The melting temperatures, determined from the plateau values, were finally corroborated by flash scanning calorimetry experiments. For the first time, the solid−solid transition between Form II and Form I has been observed by DSC at a temperature close to the calculated one (∼155°C). This matching in temperature allows the identification of this signal, even if the nature of the phase obtained after crossing this endothermic peak has not been identified yet. However, the reason why this transition occurs occasionally still remains to be understood. Based on these new findings, it can be concluded without any doubt that the two anhydrous polymorphic forms of prednisolone exhibit an enantiotropic relationship under ordinary pressure.
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